Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mouse primary hepatocytes | Mouse | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Castano et al., PNAS, 2020, 117, 48: 30335–30343, doi:10.1073/pnas.2016112117/-/DCSupplemental | ||||
Human primary hepatocytes | Human | digestive organs | primary cell | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | J.-S. Park et al., BMC Res. Notes, 2011, 4: 8, doi:10.1186/1756-0500-4-8 | Link | |||
Mouse primary hepatocytes | Mouse | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. D. Joshi et al., J. Pharmacol. Exp. Ther., Mar 2015; 353: 201 - 212 | ||||
Mouse primary hepatocytes | Mouse | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Surendran, PhD Thesis, 2014, Indiana University | ||||
Rat primary hepatocytes (Sprague Dawley rats) | Rat | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | R. Jog et al., Physiol. Reports., 2021, 9: e14991, DOI: 10.14814/phy2.14991 | Link | |||
Human primary hepatocytes | Human | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J.-S. Park et al., BMC Res. Notes, 2011, 4: 8, doi:10.1186/1756-0500-4-8 | Link | |||
Mouse primary hepatocytes | Mouse | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. S. Park et al., BMC Res Notes, Jan 2011; 4: 8 | ||||
Mouse primary hepatocytes | Mouse | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. D. Joshi et al., Mol. Pharmacol., Sept 2017, 92:366-374, doi.org/10.1124/mol.117.108878 | ||||
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. V. Rao et al., BMC Cancer, 2017, 17:68, DOI 10.1186/s12885-017-3055-5 | Link | |
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Bhandari et al., Biochem. and Biophys. Res. Commun., 2016, 475: 119-124 | |||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | T. S. Steigedal et al., In Vitro Cell. Dev.Biol. - Animal, 2013, 49: 162–169, DOI 10.1007/s11626-013-9588-2 | Link | ||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L.-K. M. Selvik et al., PLoS ONE, 2014, 9(11): e112485, doi:10.1371/journal.pone.0112485 | Link | ||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
beta-TC6 |
Mouse pancreatic tumor (insulinoma) derived ß cell line | ATCC CRL-11506 | Mouse | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Tsuruta et al., Hormone and Metabolic Research 2017, DOI: 10.1055/s-0043-121467 | ||
G1K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Mol. Pharmacol., Oct 2014; 86: 561 - 569 | |||
G500 |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Mannefeld et al., Cancer Res., May 2009; 69: 4073 - 4080 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. Priego et al., Oncotarget, 2016, 7 (29): 45060-45078 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Galán‐Martínez et al., Mol. Oncology, 2021, doi:10.1002/1878-0261.13085 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M. Arechederra et al., J. Biol. Chem., Feb 2015; 290: 4383 - 4397 |